drospirenone has been researched along with Cancer of Endometrium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YH; Lee, JM; Lee, KB; Lim, S | 1 |
| Skouby, SO | 1 |
1 review(s) available for drospirenone and Cancer of Endometrium
| Article | Year |
|---|---|
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
1 other study(ies) available for drospirenone and Cancer of Endometrium
| Article | Year |
|---|---|
The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.
Topics: Adult; Aged; Androstenes; Carcinoma, Endometrioid; Case-Control Studies; Drug Combinations; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Kaplan-Meier Estimate; Menopause, Premature; Middle Aged; Neoplasm Staging; Ovariectomy; Postoperative Complications; Young Adult | 2018 |